| Serial Number | 97830057 |
| Word Mark | APEXNK |
| Filing Date | Thursday, March 9, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, June 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 2, 2024 |
| Goods and Services | Immunostimulants; Pre-filled cell-based medicinal products, namely, medicinal products for aging, oncology and autoimmune disease; Biological tissue cultures for medical purposes; Anti-cancer preparations; Medicines for the treatment of cancer; Active pharmaceutical ingredient for western medicine, namely, pharmaceutical agents for aging, oncology and autoimmune disease; Anti-cancer agents; Antivirals; Biological preparations for the treatment of cancer; Biocides; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment; Blood for medical purposes; Adjuvants for medical purposes; Albuminous preparations for medical purposes; Pharmaceuticals, namely, immunotherapy being immunostimulators; Pharmaceutical preparations for the treatment of cancer; Stem cells for medical purposes; Reagents for medical use; Diagnostic reagents for medical use |
| Goods and Services | Biological research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Research and development in the pharmaceutical and biotechnology fields; Medical research services; Medical research and development in the field of cancer immunotherapy; Research and development of new products for others; Technological research in the field of cancer immunotherapy; Conducting technical project studies in the nature of scientific feasibility studies; Technical writing for others; Scientific laboratory services; Scientific research; Technological consultancy services in the field of cancer immunotherapy; Scientific and technological research relating to cancer immunotherapy; Culturing of cells for others for scientific research purposes; New product design services; Packaging design; Graphic design services; Custom design of prototypes; Graphic design of logos; Quality control of goods and services; Product quality testing services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 29, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 29, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Apexcella Biomedical Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 115603 TW |
| Party Name | Apexcella Biomedical Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City TW |
| Event Date | Event Description |
| Monday, March 13, 2023 | NEW APPLICATION ENTERED |
| Wednesday, March 29, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 7, 2023 | ASSIGNED TO EXAMINER |
| Thursday, December 7, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, December 7, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, December 7, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 21, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 21, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 21, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 28, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 4, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, August 21, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, August 21, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, August 21, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, November 21, 2024 | SOU TEAS EXTENSION RECEIVED |